APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline

References

1. 1.↵
   2. Corder EH,
   3. Saunders AM,
   4. Strittmatter WJ, et al

   . Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921–23 doi:10.1126/science.8346443 pmid:8346443

   Abstract/FREE Full Text
2. 2.↵
   2. Strittmatter WJ,
   3. Saunders AM,
   4. Schmechel D, et al

   . Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977–81 doi:10.1073/pnas.90.5.1977 pmid:8446617

   Abstract/FREE Full Text
3. 3.↵
   2. Jack CR Jr.,
   3. Therneau TM,
   4. Wiste HJ, et al

   . Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol 2016;15:56–64 doi:10.1016/S1474-4422(15)00323-3 pmid:26597325

   CrossRefPubMed
4. 4.↵
   2. Jack CR Jr.,
   3. Wiste HJ,
   4. Weigand SD, et al

   . Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 2014;13:997–1005 doi:10.1016/S1474-4422(14)70194-2 pmid:25201514

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Lee YM,
   3. Ha JK,
   4. Park JM, et al

   . Impact of apolipoprotein E4 polymorphism on the gray matter volume and the white matter integrity in subjective memory impairment without white matter hyperintensities: voxel-based morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI. J Neuroimaging 2016;26:144–49 doi:10.1111/jon.12207 pmid:25678236

   CrossRefPubMed
6. 6.↵
   2. Li B,
   3. Shi J,
   4. Gutman BA, et al

   . Influence of APOE genotype on hippocampal atrophy over time: an N=1925 surface-based ADNI study. PLoS One 2016;11:e0152901 doi:10.1371/journal.pone.0152901 pmid:27065111

   CrossRefPubMed
7. 7.↵
   2. Shi J,
   3. Leporé N,
   4. Gutman BA, et al

   . Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: an N = 725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp 2014;35:-3903–18 doi:10.1002/hbm.22447 pmid:24453132

   CrossRefPubMed
8. 8.↵
   2. Goñi J,
   3. Cervantes S,
   4. Arrondo G, et al

   . Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment. J Alzheimers Dis 2013;33:1009–19 doi:10.3233/JAD-2012-121174 pmid:23064258

   CrossRefPubMed
9. 9.↵
   2. Lu PH,
   3. Thompson PM,
   4. Leow A, et al

   . Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 2011;23:433–42 doi:10.3233/JAD-2010-101398 pmid:21098974

   CrossRefPubMed
10. 10.↵
    2. Honea RA,
    3. Vidoni E,
    4. Harsha A, et al

    . Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 2009;18:553–64 pmid:19584447

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Agosta F,
    3. Vossel KA,
    4. Miller BL, et al

    . Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A 2009;106:2018–22 pmid:1916476122

    Abstract/FREE Full Text
12. 12.↵
    2. Wishart HA,
    3. Saykin AJ,
    4. McAllister TW, et al

    . Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006;67:1221–24 doi:10.1212/01.wnl.0000238079.00472.3a pmid:17030756

    Abstract/FREE Full Text
13. 13.↵
    2. Pennanen C,
    3. Testa C,
    4. Boccardi M, et al

    . The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Dement Geriatr Cogn Disord 2006;22:60–66 doi:10.1159/000093263 pmid:16682795

    CrossRefPubMed
14. 14.↵
    2. Liu Y,
    3. Paajanen T,
    4. Westman E, et al

    . Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis 2010;21:947–66 doi:10.3233/JAD-2010-100201 pmid:20693633

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Lupton MK,
    3. Strike L,
    4. Hansell NK, et al

    . The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume. Neurobiol Aging 2016;40:68–77 doi:10.1016/j.neurobiolaging.2015.12.023 pmid:26973105

    CrossRefPubMed
16. 16.↵
    2. Wang X,
    3. Wang J,
    4. He Y, et al

    . Apolipoprotein E ε4 modulates cognitive profiles, hippocampal volume, and resting-state functional connectivity in Alzheimer's disease. J Alzheimers Dis 2015;45:781–95 doi:10.3233/JAD-142556 pmid:25624419

    CrossRefPubMed
17. 17.↵
    2. Susanto TA,
    3. Pua EP,
    4. Zhou J, et al

    . Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. J Alzheimers Dis 2015;45:-253–68 doi:10.3233/JAD-142451 pmid:2552495

    CrossRefPubMed
18. 18.↵
    2. Chen J,
    3. Shu H,
    4. Wang Z, et al

    . The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study. J Alzheimers Dis 2015;43:657–68 doi:10.3233/JAD-141677 pmid:25114090

    CrossRefPubMed
19. 19.↵
    2. Chen Y,
    3. Chen K,
    4. Zhang J, et al

    . Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ε4 allele. Neuropsychopharmacology 2015;40:1181–91 doi:10.1038/npp.2014.302 pmid:25403724

    CrossRefPubMed
20. 20.↵
    2. Habes M,
    3. Toledo JB,
    4. Resnick SM, et al

    . Relationship between APOE genotype and structural MRI measures throughout adulthood in the study of health in Pomerania population-based cohort. AJNR Am J Neuroradiol 2016;37:1636–42 doi:10.3174/ajnr.A4805 pmid:27173368

    Abstract/FREE Full Text
21. 21.↵
    2. Matura S,
    3. Prvulovic D,
    4. Jurcoane A, et al

    . Differential effects of the ApoE4 genotype on brain structure and function. Neuroimage 2014;89:81–91 doi:10.1016/j.neuroimage.2013.11.042 pmid:24296331

    CrossRefPubMed
22. 22.↵
    2. Shaw P,
    3. Lerch JP,
    4. Pruessner JC, et al

    . Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007;6:494–500 doi:10.1016/S1474-4422(07)70106-0 pmid:17509484

    CrossRefPubMedWeb of Science
23. 23.↵
    2. O'Dwyer L,
    3. Lamberton F,
    4. Matura S, et al

    . Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS One 2012;7:e48895 doi:10.1371/journal.pone.0048895 pmid:23152815

    CrossRefPubMed
24. 24.↵
    2. Hämäläinen A,
    3. Grau-Olivares M,
    4. Tervo S, et al

    . Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study. Neurodegener Dis 2008;5:186–89 doi:10.1159/000113698 pmid:18322386

    CrossRefPubMed
25. 25.↵
    2. Risacher SL,
    3. Shen L,
    4. West JD, et al

    ; Alzheimer's Disease Neuroimaging Initiative (ADNI). Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 2010;31:1401–18 doi:10.1016/j.neurobiolaging.2010.04.029 pmid:20620664

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Folstein MF,
    3. Folstein SE,
    4. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98 doi:10.1016/0022-3956(75)90026-6 pmid:1202204

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Zigmond AS,
    3. Snaith RP

    . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70 doi:10.1111/j.1600-0447.1983.tb09716.x pmid:6880820

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Barberger-Gateau P,
    3. Commenges D,
    4. Gagnon M, et al

    . Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 1992;40:1129–34 doi:10.1111/j.1532-5415.1992.tb01802.x pmid:1401698

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Wechsler DA

    . Wechsler Memory Scale. 3rd ed. San Antonio: Psychological Corporation; 1987
30. 30.↵
    2. Reitan RM

    . Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–76

    CrossRef
31. 31.↵
    2. Wechsler D

    . Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation; 1995
32. 32.↵
    2. Milner B

    . Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 1971;27:272–77 doi:10.1093/oxfordjournals.bmb.a070866 pmid:4937273

    FREE Full Text
33. 33.↵
    2. Buschke H,
    3. Sliwinski MJ,
    4. Kuslansky G, et al

    . Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology 1997;48:989–97 doi:10.1212/WNL.48.4.989 pmid:9109889

    Abstract/FREE Full Text
34. 34.↵
    2. Baddley A,
    3. Emslie H,
    4. Nimmo-Smith I

    . Doors and People. A Test of Visual and Verbal Recall and Recognition. Bury St. Edmunds: Thames Valley Test Company; 1994
35. 35.↵
    2. Kaplan EF,
    3. Goodglass H,
    4. Weintraub S

    . The Boston Naming Test. 2nd ed. Philadelphia: Lea & Febiger; 1983
36. 36.↵
    2. Schnider A,
    3. Hanlon RE,
    4. Alexander DN, et al

    . Ideomotor apraxia: behavioral dimensions and neuroanatomical basis. Brain Lang 1997;58:125–36 doi:10.1006/brln.1997.1770 pmid:9184099

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Roy EA

    2. Poeck K

    . Clues to the nature of disruption to limb Praxis. In: Roy EA, ed. Neuropsychological Studies of Apraxia and related Disorders. Amsterdam: North-Holland; 1985:99–109
38. 38.↵
    2. Welsh KA,
    3. Butters N,
    4. Mohs RC, et al

    . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part V: a normative study of the neuropsychological battery. Neurology 1994;44:609–14 doi:10.1212/WNL.44.4.609 pmid:8164812

    Abstract/FREE Full Text
39. 39.↵
    2. Hughes CP,
    3. Berg L,
    4. Danziger WL, et al

    . A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–72 doi:10.1192/bjp.140.6.566 pmid:7104545

    Abstract/FREE Full Text
40. 40.↵
    2. Petersen RC,
    3. Doody R,
    4. Kurz A, et al

    . Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–92 doi:10.1001/archneur.58.12.1985 pmid:11735772

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Xekardaki A,
    3. Rodriguez C,
    4. Montandon ML, et al

    . Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology 2015;274:490–99 doi:10.1148/radiol.14140680 pmid:25291458

    CrossRefPubMed
42. 42.↵
    2. Nauck M,
    3. Hoffmann MM,
    4. Wieland H, et al

    . Evaluation of the apo E genotyping kit on the LightCycler. Clin Chem 2000;46:722–24 pmid:10794760

    FREE Full Text
43. 43.↵
    2. Smith SM,
    3. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98 doi:10.1016/j.neuroimage.2008.03.061 pmid:18501637

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Fouquet M,
    3. Besson FL,
    4. Gonneaud J, et al

    . Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan. Neuropsychol Rev 2014;24:290–99 doi:10.1007/s11065-014-9263-8 pmid:25146994

    CrossRefPubMed
45. 45.↵
    2. Teipel S,
    3. Grothe MJ

    ; Alzheimer's Disease Neuroimaging Initiative. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease. Eur J Nucl Med Mol Imaging 2016;43:526–36 doi:10.1007/s00259-015-3222-3 pmid:26555082

    CrossRefPubMed
46. 46.↵
    2. Chételat G,
    3. Ossenkoppele R,
    4. Villemagne VL, et al

    . Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain 2016;139:2528–39 doi:10.1093/brain/aww159 pmid:27357349

    Abstract/FREE Full Text
47. 47.↵
    2. Raji CA,
    3. Lopez OL,
    4. Kuller LH, et al

    . White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2012;33:-834.e7–16 doi:10.1016/j.neurobiolaging.2011.08.010 pmid:21943959

    CrossRefPubMed
48. 48.↵
    2. Perkins M,
    3. Wolf AB,
    4. Chavira B, et al

    . Altered energy metabolism pathways in the posterior cingulate in young adult apolipoprotein E ε4 carriers. J Alzheimers Dis 2016;53:95–106 doi:10.3233/JAD-151205 pmid:21943959

    CrossRefPubMed
49. 49.↵
    2. Lu H,
    3. Fung AW,
    4. Chan SS, et al

    . Disturbance of attention network functions in Chinese healthy older adults: an intra-individual perspective. Int Psychogeriatr 2016;28:291–301 doi:10.1017/S1041610215001556 pmid:26412555

    CrossRefPubMed
50. 50.↵
    2. Albert MS,
    3. DeKosky ST,
    4. Dickson D, et al

    . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–79 doi:10.1016/j.jalz.2011.03.008 pmid:21514249

    CrossRefPubMedWeb of Science